Clinical trial
Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women
NCT02028364
Study timeline
Study start (unknown)2014-01-12Date precision: day
Registry last updated2023-08-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
EverolimusDRUG · verified · RxNorm: everolimus
ExemestaneDRUG · verified · RxNorm: exemestane
Sponsors & collaborators
Jules Bordet Institutelead sponsor
Novartiscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02028364 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.